Inderpal Singh has a rich and impactful career dedicated to tackling challenging global issues.

With a background in data analytics, software and hardware development, he played a pivotal role at Kinsa by spearheading the creation of an early warning system for outbreaks, which led to significant business growth and catered to Fortune 100 customers, major health systems, and millions of consumers during and after the Covid pandemic.

During his tenure at the Clinton Health Access Initiative (CHAI), Inderpal excelled in negotiating deals that revolutionized drug pricing for AIDS and malaria, resulting in substantial cost savings for developing nations and facilitating the introduction of 40 new treatments.

With a diverse educational portfolio, including degrees from prestigious institutions like MIT Sloan School of Management, Massachusetts Institute of Technology, and Harvard Kennedy School, Inderpal possesses a unique blend of skills encompassing business, technology, public policy, and engineering.

His vast experience spans across various organizations and roles, from being the Founder & CEO at Kinsa to serving as the Executive Vice President at the Clinton Health Access Initiative, Inc., and contributing to renowned institutions like the World Health Organization and Council on Foreign Relations.

Driven by his passion for creating impact, Inderpal is now seeking new opportunities within or outside the healthcare sector, with a keen interest in leveraging his expertise in product development, sales, deal brokering, and technology-driven value creation.

Apart from his professional pursuits, he is also interested in engaging in CEO and corporate advising roles, teaching, and speaking on topics like entrepreneurship, social impact through capitalism, and cross-sector partnerships.